Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.10), $0.19 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.51 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.